GAA
MRNA icon

Green Alpha Advisors’s Moderna MRNA Stock Holding History

Green Alpha Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.39M Sell
33,191
-567
-2% -$61.1K 4.33% 4
2026
Q2 		$2.36M Sell
33,758
-580
-2% -$30K 1.59% 18
2026
Q1 		$1.74M Buy
34,338
+1,182
+4% +$55.1K 1.72% 18
2025
Q4 		$978K Buy
33,156
+5,015
+18% +$136K 0.9% 31
2025
Q3 		$727K Sell
28,141
-3,130
-10% -$87.3K 0.7% 48
2025
Q2 		$863K Buy
31,271
+2,597
+9% +$68.4K 0.82% 41
2025
Q1 		$813K Buy
28,674
+11,774
+70% +$418K 0.87% 34
2024
Q4 		$703K Buy
16,900
+5,987
+55% +$286K 0.56% 61
2024
Q3 		$729K Buy
10,913
+637
+6% +$58.5K 0.57% 64
2024
Q2 		$1.22M Sell
10,276
-2,676
-21% -$339K 0.98% 33
2024
Q1 		$1.38M Buy
12,952
+1,354
+12% +$136K 1% 32
2023
Q4 		$1.15M Sell
11,598
-133
-1% -$11.2K 0.83% 37
2023
Q3 		$1.21M Buy
11,731
+622
+6% +$69.4K 0.93% 36
2023
Q2 		$1.35M Buy
11,109
+1,311
+13% +$175K 0.89% 41
2023
Q1 		$1.5M Sell
9,798
-741
-7% -$122K 1.06% 28
2022
Q4 		$1.89M Buy
10,539
+1,604
+18% +$262K 1.57% 8
2022
Q3 		$1.06M Sell
8,935
-77,650
-90% -$11.8M 0.9% 35
2022
Q2 		$12.4M Buy
86,585
+78,801
+1,012% +$11.3M 2.84% 8
2022
Q1 		$1.34M Buy
7,784
+721
+10% +$121K 0.9% 42
2021
Q4 		$1.79M Buy
7,063
+326
+5% +$95.3K 1.21% 24
2021
Q3 		$2.59M Sell
6,737
-885
-12% -$326K 1.79% 3
2021
Q2 		$1.79M Sell
7,622
-4,998
-40% -$893K 1.22% 19
2021
Q1 		$1.65M Sell
12,620
-1,944
-13% -$282K 1.64% 14
2020
Q4 		$1.52M Buy
+14,564
New +$1.47M 1.84% 14

Other funds holding MRNA

FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
LHWM
Lake Hills Wealth Management Austin, Texas $218M AUM 31.66% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
G
Gainplan Bloomfield Hills, Michigan $258M AUM 17.9% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Green Alpha Advisors's MRNA Position: Q3 2026 in Review

Green Alpha Advisors reduced its Moderna (MRNA) stake by 1.7% in Q3 2026, selling an estimated $61.1K and leaving 33,191 shares worth $6.39M. The position accounts for 4.33% of the portfolio, ranked #4.

Green Alpha Advisors first reported a position in MRNA in Q4 2020 and has held it in 24 quarters since. The position peaked at $12.4M in Q2 2022. 24 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • Green Alpha Advisors held 33,191 shares of Moderna worth $6.39M as of Q3 2026.
  • Green Alpha Advisors sold 567 Moderna shares in Q3 2026, an estimated $61.1K.
  • Moderna made up 4.33% of Green Alpha Advisors's portfolio in Q3 2026, its #4 holding.
  • Green Alpha Advisors first reported a position in Moderna in Q4 2020 and has held it in 24 quarters since.
  • Green Alpha Advisors's Moderna position peaked at $12.4M in Q2 2022.
  • 24 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Green Alpha Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.